Sorafenib inhibits transforming growth factor β1-Mediated Epithelial-Mesenchymal Transition and apoptosis in mouse hepatocytes
Epithelial-mesenchymal transition (EMT) is a physiological process that has been recognized to occur during the progression of an increasingly large number of human diseases, including liver fibrosis, cirrhosis, and hepatocellular carcinoma. The activation of transforming growth factor β (TGF-β) sig...
Αποθηκεύτηκε σε:
Κύριοι συγγραφείς: | Yue‐Lei Chen, Jing Lv, Xiaolei Ye, Mingyu Sun, Qin Xu, Chenghai Liu, Lihua Min, Huiping Li, Ping Liu, Xiaoyan Ding |
---|---|
Μορφή: | Artigo |
Γλώσσα: | Αγγλικά |
Έκδοση: |
2011
|
Διαθέσιμο Online: | https://doi.org/10.1002/hep.24254 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.24254 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells
από: Zhang, Juyong, κ.ά.
Έκδοση: (2013) -
Sorafenib Inhibits the Hepatocyte Growth Factor–Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
από: Tomoyuki Nagai, κ.ά.
Έκδοση: (2011) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
από: Yanru Deng, κ.ά.
Έκδοση: (2016) -
Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
από: Deng, Yan-Ru, κ.ά.
Έκδοση: (2016) -
The hepatocyte-specifically expressed lnc-HSER alleviates hepatic fibrosis by inhibiting hepatocyte apoptosis and epithelial-mesenchymal transition
από: Zhang, Kun, κ.ά.
Έκδοση: (2019)